BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14698799)

  • 1. Modeling the use of innovations in private treatment organizations: the role of absorptive capacity.
    Knudsen HK; Roman PM
    J Subst Abuse Treat; 2004 Jan; 26(1):353-61. PubMed ID: 14698799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of antidepressant medications in substance abuse treatment: the public-private distinction, organizational compatibility, and the environment.
    Knudsen HK; Ducharme LJ; Roman PM
    J Health Soc Behav; 2007 Jun; 48(2):195-210. PubMed ID: 17583274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retaining counseling staff at substance abuse treatment centers: effects of management practices.
    Knudsen HK; Johnson JA; Roman PM
    J Subst Abuse Treat; 2003 Mar; 24(2):129-35. PubMed ID: 12745030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Science-based and practice-based innovativeness and performance of substance abuse treatment facilities.
    Nayar P; Yu F; Apenteng B
    Health Care Manage Rev; 2014; 39(1):66-74. PubMed ID: 23358133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers.
    Bride BE; Abraham AJ; Roman PM
    J Subst Abuse Treat; 2011 Jan; 40(1):87-94. PubMed ID: 20850259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A categorical typology of naltrexone-adopting private substance abuse treatment centers.
    Oser CB; Roman PM
    J Subst Abuse Treat; 2008 Jun; 34(4):433-42. PubMed ID: 17997266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between addiction treatment staff professional and educational levels and perceptions of organizational climate and resources.
    Krull I; Lundgren L; Beltrame C
    Subst Abus; 2014; 35(1):3-6. PubMed ID: 24588286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative culture in long-term care settings: the influence of organizational characteristics.
    Nieboer AP; Strating MM
    Health Care Manage Rev; 2012; 37(2):165-74. PubMed ID: 21720249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting closure of private substance abuse treatment facilities.
    Johnson JA; Roman PM
    J Behav Health Serv Res; 2002 May; 29(2):115-25. PubMed ID: 12032969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addiction treatment provider attitudes on staff capacity and evidence-based clinical training: results from a national study.
    Lundgren L; Amodeo M; Krull I; Chassler D; Weidenfeld R; de Saxe Zerden L; Gowler R; Lederer J; Cohen A; Beltrame C
    Am J Addict; 2011; 20(3):271-84. PubMed ID: 21477056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital organization culture, capacity to innovate and success in technology adoption.
    Caccia-Bava Mdo C; Guimaraes T; Harrington SJ
    J Health Organ Manag; 2006; 20(2-3):194-217. PubMed ID: 16869354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-level examination of how the organizational context relates to readiness to implement prevention and evidence-based programming in community settings.
    Chilenski SM; Olson JR; Schulte JA; Perkins DF; Spoth R
    Eval Program Plann; 2015 Feb; 48():63-74. PubMed ID: 25463014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adopting evidence-based medically assisted treatments in substance abuse treatment organizations: roles of leadership socialization and funding streams.
    Blum TC; Davis CD; Roman PM
    J Health Hum Serv Adm; 2014; 37(1):37-75. PubMed ID: 25004707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multidimensional Study of Absorptive Capacity and Innovation Capacity and Their Impact on Business Performance.
    Sancho-Zamora R; Gutiérrez-Broncano S; Hernández-Perlines F; Peña-García I
    Front Psychol; 2021; 12():751997. PubMed ID: 34764918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multilevel approach to predicting community addiction treatment attitudes about contingency management.
    Hartzler B; Donovan DM; Tillotson CJ; Mongoue-Tchokote S; Doyle SR; McCarty D
    J Subst Abuse Treat; 2012 Mar; 42(2):213-21. PubMed ID: 22138199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use treatment counselors' attitudes toward evidence-based practice: the importance of organizational context.
    Smith BD
    Subst Use Misuse; 2013 Apr; 48(5):379-90. PubMed ID: 23421387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicians in the substance abuse treatment workforce: understanding their employment within publicly funded treatment organizations.
    Knudsen HK; Oser CB; Abraham AJ; Roman PM
    J Subst Abuse Treat; 2012 Sep; 43(2):152-60. PubMed ID: 22301083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ownership differences in the provision of outpatient substance abuse services.
    Burke AC; Rafferty JA
    Adm Soc Work; 1994; 18(3):59-91. PubMed ID: 10138940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
    Wells R; Lemak CH; D'Aunno TA
    Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care administrators' perspectives on the role of absorptive capacity for strategic change initiatives: a qualitative study.
    Kash BA; Spaulding A; Gamm L; Johnson CE
    Health Care Manage Rev; 2013; 38(4):339-48. PubMed ID: 23135101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.